<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Potsdam_Bioware_Lab_Labjournal_June"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Potsdam_Bioware/Lab/Labjournal/June">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Potsdam_Bioware/Lab/Labjournal/June&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Potsdam_Bioware/Lab/Labjournal/June&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Potsdam_Bioware/Lab/Labjournal/June&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Potsdam_Bioware/Lab/Labjournal/June" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Potsdam Bioware/Lab/Labjournal/June</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><DIV class="nav_menu gradient_golden"><DIV id="menu_center"><UL id="menu"><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware">Home</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/At_a_Glance">Project</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/At_a_Glance">At a Glance</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/At_a_Glance#Main_Results">Main Results</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/Part_AID">Mutation Module</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/Part_Antibody">Antibody Module</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/Part_Virus">Selection Module</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/Modeling">Modeling</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/Potsdam Standard">Potsdam Standard</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Project/Collaboration">Collaboration</A></LI></UL><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Team/Members">Team</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Team/Members">Members</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Team/Sponsoring">Sponsoring</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Team/Attribution">Attribution</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Lab/Labjournal">Lab</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Lab/Labjournal">Labjournal</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Lab/Group_Meetings">Group Meetings</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Lab/Protocols">Protocols</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Lab/Safety">Safety</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Biobricks/Overview">BioBricks</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Biobricks/Overview">Overview</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Biobricks/All_Biobricks">All Biobricks</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/SocialBrick">SocialBricks</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/SocialBrick">Overview</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/SocialBrick/Science_Meets_Politics">Science Meets Politics</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/SocialBrick/Science_Meets_People">Science Meets People</A></LI><LI><A href="https://2012.igem.org/Team:Potsdam_Bioware/Software">Software</A></LI></DIV></DIV><DIV class="box_round white_bg"><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#AID-Group"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">AID-Group</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#1st_Labday_2012-06-09"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">1st Labday 2012-06-09</SPAN></A></LI><LI class="toclevel-2 tocsection-3"><A href="#2012-06-24"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">2012-06-24</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#2012-06-25"><SPAN class="tocnumber">1.3</SPAN><SPAN class="toctext">2012-06-25</SPAN></A></LI><LI class="toclevel-2 tocsection-5"><A href="#2012-06-27"><SPAN class="tocnumber">1.4</SPAN><SPAN class="toctext">2012-06-27</SPAN></A></LI><LI class="toclevel-2 tocsection-6"><A href="#2012-06-28"><SPAN class="tocnumber">1.5</SPAN><SPAN class="toctext">2012-06-28</SPAN></A></LI></UL><LI class="toclevel-1 tocsection-7"><A href="#Antik.C3.B6rper"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext">Antikörper</SPAN></A></LI><LI class="toclevel-2 tocsection-8"><A href="#2012-06-11"><SPAN class="tocnumber">2.1</SPAN><SPAN class="toctext">2012-06-11</SPAN></A></LI><LI class="toclevel-2 tocsection-9"><A href="#2012-06-13"><SPAN class="tocnumber">2.2</SPAN><SPAN class="toctext">2012-06-13</SPAN></A></LI><LI class="toclevel-2 tocsection-10"><A href="#2012-06-15"><SPAN class="tocnumber">2.3</SPAN><SPAN class="toctext">2012-06-15</SPAN></A></LI><LI class="toclevel-2 tocsection-11"><A href="#2012-06-19"><SPAN class="tocnumber">2.4</SPAN><SPAN class="toctext">2012-06-19</SPAN></A></LI><LI class="toclevel-2 tocsection-12"><A href="#2012-06-20"><SPAN class="tocnumber">2.5</SPAN><SPAN class="toctext">2012-06-20</SPAN></A></LI><LI class="toclevel-2 tocsection-13"><A href="#2012-06-22"><SPAN class="tocnumber">2.6</SPAN><SPAN class="toctext">2012-06-22</SPAN></A></LI><LI class="toclevel-2 tocsection-14"><A href="#2012-06-22_2"><SPAN class="tocnumber">2.7</SPAN><SPAN class="toctext">2012-06-22</SPAN></A></LI><LI class="toclevel-2 tocsection-15"><A href="#2012-06-27_2"><SPAN class="tocnumber">2.8</SPAN><SPAN class="toctext">2012-06-27</SPAN></A></LI><LI class="toclevel-1 tocsection-16"><A href="#Virus"><SPAN class="tocnumber">3</SPAN><SPAN class="toctext">Virus</SPAN></A></LI><LI class="toclevel-2 tocsection-17"><A href="#2012-06-07"><SPAN class="tocnumber">3.1</SPAN><SPAN class="toctext">2012-06-07</SPAN></A></LI><LI class="toclevel-2 tocsection-18"><A href="#2012-06-14"><SPAN class="tocnumber">3.2</SPAN><SPAN class="toctext">2012-06-14</SPAN></A></LI><LI class="toclevel-2 tocsection-19"><A href="#2012-06-19_2"><SPAN class="tocnumber">3.3</SPAN><SPAN class="toctext">2012-06-19</SPAN></A></LI><LI class="toclevel-2 tocsection-20"><A href="#2012-06-22_3"><SPAN class="tocnumber">3.4</SPAN><SPAN class="toctext">2012-06-22</SPAN></A></LI><LI class="toclevel-2 tocsection-21"><A href="#2012-06-28_2"><SPAN class="tocnumber">3.5</SPAN><SPAN class="toctext">2012-06-28</SPAN></A></LI><LI class="toclevel-2 tocsection-22"><A href="#2012-06-29"><SPAN class="tocnumber">3.6</SPAN><SPAN class="toctext">2012-06-29</SPAN></A></LI></TD></TR></TBODY></TABLE><H2><SPAN class="mw-headline" id="AID-Group">AID-Group</SPAN></H2><H3><SPAN class="mw-headline" id="1st_Labday_2012-06-09"><P style="background-color: rgb(240, 20, 70);">1st Labday 2012-06-09</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Planing the wildtype AID construct (BBa_K929000)</P><P><B>Investigators:</B> Tom S., Chris, Basia, Rico, Mario, Kevin </P><P><B>Aim:</B> planing the construction of the wildtype AID in pSB1C3</P><P><B>Material:</B> Genious </P><P><B>Results:</B></P><UL><LI> pSB1C3 with CMV -&gt; (cut with SpeI and PstI) 2715 bp (CMV insert+backbone) + 18 bp (rest)
</LI></UL><UL><LI> pSB1A3 with AID -&gt; (cut with XbaI and PstI) 626 bp (AID insert) + 2061 bp (backbone)
</LI></UL><UL><LI> pSB1C3 with hGH -&gt; (cut with XbaI and PstI) 505 bp (hGH insert) + 2053 bp (backbone)
</LI></UL><P><B>Further tasks:</B></P><UL><LI> practice part
</LI></UL><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Planing the modified AID construct (BBa_K929002)</P><P><B>Investigators:</B> Tom S., Chris, Basia, Rico, Mario, Kevin </P><P><B>Aim:</B> planing the modified AID with Kozak sequence, NLS and without NES, Primer design</P><P><B>Material:</B> Genious </P><P><B>Results:</B></P><UL><LI> reverse primer without NES
</LI></UL><P><B>Further tasks:</B></P><UL><LI> design of the forward primer
</LI></UL><UL><LI> design of the practice part
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-24"><P style="background-color: rgb(240, 20, 70);"> 2012-06-24</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: Preparation of overnight culture of <I>E. coli</I> strain XL-1 Blue</P><P><B>Investigators:</B></P><P>Basia </P><P><B>Aim:</B></P><P>preparation of competent cells of <I>E. coli</I> strain XL-1 Blue
</P><P><B>Materials:</B></P><P>LB Medium, Tetracycline, XL-1 Blue stock
</P><P><B>Method:</B></P><P>Competent <I>E. coli</I> -&gt; Standard protocols
</P><P><B>Results:</B></P><P>culture grew
</P><P><B>Further tasks:</B></P><P>further preparation of competent cells with MgCl2 and CaCl2.</P><H3><SPAN class="mw-headline" id="2012-06-25"><P style="background-color: rgb(240, 20, 70);"> 2012-06-25</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: making competent XL1 Blue <I>E. coli</I></P><P><B>Investigators:</B></P><P>Sascha, Maria, Tarek, Chris </P><P><B>Aim:</B></P><P>get competent <I>E. coli</I> Xl1 Blue
</P><P><B>Materials:</B></P><P>CaCl2, Glycerol, overnight culture
</P><P><B>Method:</B></P><P>Competent <I>E. coli</I> -&gt; Standard protocols
</P><P><B>Results:</B></P><UL><LI> ca. 80 (100 µL) Stocks frozen competent <I>E. coli</I> XL1 Blue
</LI></UL><UL><LI> location: competent <I>E. coli</I> Xl1 Blue in -80°C Freezer
</LI></UL><P><B>Further tasks:</B></P><UL><LI> testing ability for transformation of competent cells
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-27"><P style="background-color: rgb(240, 20, 70);"> 2012-06-27</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: Picking clones/start overnight culture: AID(BBa_K103001); start overnight culture with pcdna5/ftr

</P><P><B>Investigators:</B></P><P>Chris, Mario </P><P><B>Aim:</B></P><P>Picking clones/start 5 mL culture: 2 * 5 mL, 1*20 mL for Miniprep AID(BBa_K103001) &amp; glycerolstock; 1 * 5 mL (Plasmid Sascha:pcdna5/frt) per competent cell line (&quot;good&quot;, &quot;bad&quot; and &quot;AG&quot;)
</P><P><B>Materials:</B></P><P><I>E. coli</I> colonies from agar-plates (antibiotic: Amp), test tubes+ 5 mL LB+1:1000 AMP, 37 °C shaker
</P><P><B>Method:</B></P><P>picking clones, inoculate in 5 mL fresh LB-media with Ampicilin (1:1000), incubation over night
</P><P><B>Results:</B></P><P>ready for Miniprep: 2*5 mL and 1*20 mL <I>E. coli</I> XL1 with AID(BBa_K103001); 1 * 5 mL (Plasmid Sascha:pcdna5/frt) per competent cell line (&quot;good&quot;, &quot;bad&quot; and &quot;AG&quot;)
</P><UL><LI> location: incubator 37 °C</LI></UL><P><B>Further tasks:</B></P><UL><LI>Preparation of glycerol stocks (one of XL1 with AID (BBa_K103001), one of XL1 with pcdna5/frt)
</LI></UL><UL><LI>Miniprep Thursday 28.06.2012
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-28"><P style="background-color: rgb(240, 20, 70);"> 2012-06-28</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: MiniPrep of AID(BBa_K103001) and pcdna5/frt + preparation of cryostocks of the cells</P><P><B>Investigators:</B>Basia </P><P><B>Aim:</B></P><P>Miniprep &amp; glycerol stock AID(BBa_K103001); Miniprep and cryostock of pcdna5/frt per competent cell line (&quot;good&quot;, &quot;bad&quot; and &quot;AG&quot;)
</P><P><B>Materials:</B></P><P>Cells grown in test tubes, Miniprep Kit, glycerin, centrifuge
</P><P><B>Method:</B></P><P>Glycerol stock: 500 µL of 100 % Glycerin + 500 µL of the liquid overnight culture
</P><P>MiniPrep: according to the manual
</P><P><B>Results:</B></P><P>ready plasmids AID(BBa_K103001) and pcdna5/frt per competent cell line (&quot;good&quot;, &quot;bad&quot; and &quot;AG&quot;)
</P><UL><LI> location: Plasmids: AID(BBa_K103001)- 4th drawer in the -20 °C freezer, pcdna5/frt per competent cell line (&quot;good&quot;, &quot;bad&quot; and &quot;AG&quot;)-2nd drawer in the -20 °C freezer
</LI></UL><P>Glycerolstocks-box in -80 °C freezer marked with the green tape with a label(BM 28.6.2012, iGEM, AID, pcdna5/FRT)
</P><P><B>Further tasks:</B></P><P>Gel electrophoresis for AID to check if it is intact.
</P><H2><SPAN class="mw-headline" id="Antik.C3.B6rper">Antikörper</SPAN></H2><H3><SPAN class="mw-headline" id="2012-06-11"><P style="background-color: rgb(240, 20, 70);">2012-06-11</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Culture of CHO-Flp-In Cells</P><P><B>Investigators:</B> Stefan, Tarek </P><P><B>Aim:</B> Thawing of CHO-Flp-In Cells </P><P><B>Date/Time:</B> 2012-06-11,11-20:00 </P><P><B>Materials:</B></P><UL><LI> Cryostock of CHO-Flp-In Cells
</LI></UL><UL><LI> Complete Medium (Ham´s F12 + 10% FBS + 1% Pen/Strep + 2 mM L-Glutamin)
</LI></UL><UL><LI> Zeocin
</LI></UL><UL><LI> 75 cm² culture flask
</LI></UL><P><B>Method:</B></P><P>Growth and Maintenance of Flp-In Cell Lines (Invtrogen):
</P><UL><LI> incubation of thawed cells in 12 ml complete medium without Zeocin for 3h
</LI></UL><UL><LI> change of medium (get rid of DMSO) and incubation overnight 37°C , 5% CO2
</LI></UL><P><B>Results:</B></P><UL><LI> 1x 75cm² culture flask with attached cells
</LI></UL><P><B>Further tasks:</B></P><UL><LI> change medium against medium with 100 µg/ml Zeocin (done on 2012-06-12)
</LI></UL><UL><LI> change medium after 2-3 days (done on 2012-06-14)
</LI></UL><UL><LI> get the cells to 80-90% confluence (daily check) for splitting
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-13"><P style="background-color: rgb(240, 20, 70);">2012-06-13</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Plasmid DNA Purification</P><P><B>Investigators:</B> Kerstin, Maria</P><P><B>Aim:</B> Purification of Plasmids pFRT/lacZeo,pcDNA5/FRT, pOG44</P><P><B>Date/Time:</B> 2012-06-13,12:00-14.00 </P><P><B>Materials:</B> Macherey-Nagel Purification Kit</P><UL><LI> E.coli XL-1 blue culture transformed with pFRT/lacZeo, pcDNA5/FRT, pOG44
</LI></UL><UL><LI> 2 clones of each plasmid
</LI></UL><UL><LI> 2 ml of each culture taken
</LI></UL><P><B>Method:</B> Plasmid purification (Miniprep)</P><P>Protocol-at-a-glance (Macherey-Nagel)
</P><UL><LI> pellet of 2 ml from each culture
</LI></UL><P>variation: centrifugation steps 1 min instead of 30 sec
</P><P><B>Results:</B></P><P>Plasmids pFRT/lacZeo, pcDNA5/FRT, pOG44</P><UL><LI> location: freezer -20°, Box2
</LI></UL><P><B>Further tasks:</B></P><UL><LI> measurement of DNA concentration
</LI></UL><UL><LI> control with restriction digest
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-15"><P style="background-color: rgb(240, 20, 70);">2012-06-15</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Culture of CHO-Flp-In Cells</P><P><B>Investigators:</B> Tarek </P><P><B>Aim:</B> Splitting of CHO-Flp-In Cells </P><P><B>Date/Time:</B> 2012-06-15, 14-16:00 </P><P><B>Materials:</B></P><UL><LI> 1 x 75 cm² flask with confluent CHO-Flp-In Cells
</LI></UL><UL><LI> 8 x 75 cm² culture flasks
</LI></UL><UL><LI> complete Medium with Zeocin
</LI></UL><UL><LI> PBS
</LI></UL><UL><LI> Trypsin/EDTA
</LI></UL><P><B>Method:</B></P><P>Growth and Maintenance of Flp-In Cell Lines (Invitrogen):
</P><UL><LI> remove medium and wash the cells with 10 ml PBS
</LI></UL><UL><LI> Add 2 ml Trypsin/EDTA solution (ca. 3 min ´til the cells detached)
</LI></UL><UL><LI> Add 8 ml of complete medium (+Zeocin), and briefly resuspend the cells
</LI></UL><UL><LI> 1 x 2 ml of the cellsuspension in 13 ml complete medium (1:5 splitting)
</LI></UL><UL><LI> 7 x 1 ml of the cellsuspension in 14 ml complete medium (1:10 splitting)
</LI></UL><UL><LI> incubation 37°C, 5% CO2
</LI></UL><P><B>Results:</B></P><UL><LI> 1 x 1:5 CHO-Flp-In Cells
</LI></UL><UL><LI> 7 x 1:10 CHO-Flp-In Cells
</LI></UL><P><B>Further tasks:</B></P><UL><LI> get the cells to 90% confluence
</LI></UL><UL><LI> freezing cells
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-19"><P style="background-color: rgb(240, 20, 70);">2012-06-19</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Culture of CHO-Flp-In Cells</P><P><B>Investigators:</B> Stefan, Tarek </P><P><B>Aim:</B> Freezing and passaging cultured CHO-Flp-In Cells </P><P><B>Date/Time:</B> 2012-06-19, 10-12:00 </P><P><B>Materials:</B></P><UL><LI> confluent CHO-Flp-In Cells
</LI></UL><UL><LI> Complete Medium
</LI></UL><UL><LI> Freezing Medium (90% Complete Medium + 10% DMSO)
</LI></UL><UL><LI> PBS
</LI></UL><UL><LI> Trypsin/EDTA
</LI></UL><UL><LI> Neubauerzählkammer
</LI></UL><UL><LI> Falcon-tubes (15ml + 50ml)
</LI></UL><P><B>Method:</B></P><P>Growth and Maintenance of Flp-In Cell Lines (Invitrogen);
</P><P>Freezing Cells:
</P><UL><LI> prepare 20 ml of Freezing medium; label cryovials
</LI></UL><UL><LI> trypsinate the cells (like 2012-06-15); 5 x 75 cm² flasks
</LI></UL><UL><LI> counting the cells in Neubauerzählkammer = 2,3 x 10e6/ml = 2,3 x 10e7/flask = 5 Cryostocks per flask á 4,6 x 10e6 cells (min 3 x 10e6 cells/ml)
</LI></UL><UL><LI> centrifugate the cells in two 50 ml falcon tubes (á 25 ml) and aspirate off the medium
</LI></UL><UL><LI> resuspend the cellpellets in 10 ml freezing medium
</LI></UL><UL><LI> add 1 ml cell suspension into one cryovial (x20)
</LI></UL><UL><LI> place the vials in a styroporbox and freeze them in -80°C Freezer
</LI></UL><UL><LI> passaging cells (2 x 75 cm² flasks) was done like on 2012-06-15
</LI></UL><P><B>Results:</B></P><UL><LI> 19 cryovials with CHO-Flp-In Cells
</LI></UL><UL><LI> 2 x 1:10 CHO Flp-In Cells
</LI></UL><P><B>Further tasks:</B></P><UL><LI> reactivate one cryostock
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-20"><P style="background-color: rgb(240, 20, 70);">2012-06-20</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Culture of CHO-Flp-In Cells</P><P><B>Investigators:</B> Tarek </P><P><B>Aim:</B> Reactivate/Thawing CHO-Flp-In Cryostock </P><P><B>Date/Time:</B> 2012-06-20, 12-13 </P><P><B>Materials:</B></P><UL><LI> Cryostock of CHO-Flp-In Cells
</LI></UL><UL><LI> Complete Medium (Ham´s F12 + 10% FBS + 1% Pen/Strep + 2 mM L-Glutamin)
</LI></UL><UL><LI> Zeocin
</LI></UL><UL><LI> 75 cm² culture flask
</LI></UL><P><B>Method:</B></P><P>Growth and Maintenance of Flp-In Cell Lines (Invitrogen):
</P><P>changes to 2012-06-11:
</P><UL><LI> resuspend the thawed cells in 12 ml complete medium and centrifugate (to save 3h), 250 g, 5 min, RT
</LI></UL><UL><LI> aspirate off the medium
</LI></UL><UL><LI> resuspend the cells in complete medium (5ml)
</LI></UL><UL><LI> place the resuspended cells in a culture flasks with 10ml complete medium + 15 µl Zeocin
</LI></UL><P><B>Results:</B></P><UL><LI> 1 x 75 cm² flasks with reactivated crystock of CHO-Flp-In Cells
</LI></UL><P><B>Further tasks:</B></P><UL><LI> change medium
</LI></UL><UL><LI> get reactivated cryostock to confluence
</LI></UL><UL><LI> splitting cells
</LI></UL><UL><LI> freeze second charge of cells
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-22"><P style="background-color: rgb(240, 20, 70);">2012-06-22</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Culture of CHO-Flp-In Cells</P><P><B>Investigators:</B> Tarek </P><P><B>Aim:</B> Splitting Cells for 2nd freezing charge </P><P><B>Date/Time:</B> 2012-06-22, 15-16:00 </P><P><B>Materials:</B></P><UL><LI> confluent CHO-Flp-In Cells (reactivated cryostock)
</LI></UL><UL><LI> 5 x 75 cm² culture flasks
</LI></UL><UL><LI> complete medium + Zeocin
</LI></UL><UL><LI> PBS
</LI></UL><UL><LI> Trypsin/EDTA
</LI></UL><P><B>Method:</B></P><P>like 2012-06-15
</P><P><B>Results:</B></P><UL><LI> 5 x 75 cm² CHO-flp-In Cells
</LI></UL><P><B>Further tasks:</B></P><UL><LI> get cells 90% confluence
</LI></UL><UL><LI> freeze cells
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-22_2"><P style="background-color: rgb(240, 20, 70);">2012-06-22</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Planning the antibody construct</P><P><B>Investigators:</B> Maria, Sascha </P><P><B>Aim:</B> Draft for gene construct, searching appropriate Fc-part </P><P><B>Date/Time:</B> 2012-06-22, 14:00 - 16:30 </P><P><B>Materials:</B></P><UL><LI> Databases
</LI></UL><UL><LI> Paper
</LI></UL><P><B>Method:</B></P><P>reviewing of sequences
</P><P><B>Results:</B></P><UL><LI> nucleotide sequence of human C-kappa1 gene
</LI></UL><P><B>Further tasks:</B></P><UL><LI> further search for sequences
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-27_2"><P style="background-color: rgb(240, 20, 70);">2012-06-27</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Planning the antibody construct</P><P><B>Investigators:</B> Sascha, Maria </P><P><B>Aim:</B> Draft for gene construct </P><P><B>Date/Time:</B> 2012-06-28,17:30-23:45 </P><P><B>Materials:</B></P><UL><LI> Databases
</LI></UL><UL><LI> Geneious
</LI></UL><UL><LI> Paper
</LI></UL><P><B>Method:</B></P><P>Planning and reviewing of sequence
</P><P><B>Results:</B></P><UL><LI> antibody construct with exon/intron structure
</LI></UL><P><B>Further tasks:</B></P><UL><LI> meeting with Dr. Kappel (Monday) and Prof. Lenhard (Wednesday) for clarification of exon/intron structure
</LI></UL><UL><LI> further control
</LI></UL><UL><LI> ordering of gene synthesis
</LI></UL><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Primer-Design for GATC-sequencing of pcDNA5-FRT and pOG44; vectors for stable transfection</P><P><B>Investigators:</B> Sascha, Maria, Tarek </P><P><B>Aim:</B> Primer-Design for pcDNA5-FRT and pOG44 </P><P><B>Materials:</B></P><UL><LI> lablife: sequences of invitrogen vectors pcDNA5-FRT and pOG44
</LI></UL><UL><LI> Oligocalc to calculate Tm of primers based on GATC-requirements
</LI></UL><UL><LI> Geneious
</LI></UL><P><B>Results:</B></P><UL><LI> forward-primer for CMV-promotor in pcDNA5-FRT and pOG44
</LI></UL><UL><LI> reverse-primer for pcDNA5-FRT in hygromycin at N-terminus
</LI></UL><UL><LI> reverse-primer for pOG44 in N-terminus of flp-gene
</LI></UL><P><B>Further tasks:</B></P><UL><LI> ordering of primers at GATC
</LI></UL><UL><LI> preparation of pcDNA5-FT, pOG44 and ordered primers based on requirements of GTAC
</LI></UL><H2><SPAN class="mw-headline" id="Virus">Virus</SPAN></H2><H3><SPAN class="mw-headline" id="2012-06-07"><P style="background-color: rgb(240, 20, 70);"> 2012-06-07</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: Primer design -Cloning: Sortase-Tag an VP2 + PCR for VP2 with Kozak-sortase_tag-myc_tag </P><P><B>Investigators:</B> Kathi, Laura, Tobias, Xenia </P><P><B>Aim:</B> Primer design of VP2 region </P><P><B>Materials:</B></P><UL><LI> Vector:P10_pSB1C3_001_CMV_DARPin_ML_VP2/3_587KO_6xHis
</LI></UL><UL><LI> Sortase-sequence: amino acid sequence: LTAPG translated to gene sequence: CTTACAGCCCCAGGA
</LI></UL><UL><LI> restriction sites: NgoMIV</LI></UL><P><B>Method:</B> Geneious </P><P><B>Results:</B></P><UL><LI> f_Primer_preNgoMIV+SortaseMotiv1+VP2
</LI></UL><UL><LI> r_Primer_VP2_1</LI></UL><P><B>Further tasks:</B></P><UL><LI>check the primer
</LI></UL><P><B>Changes:</B></P><UL><LI> primer for cmv region:
</LI></UL><UL><LI> include restriction sites SpeI and XbalI, remove NgoMIV
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-14"><P style="background-color: rgb(240, 20, 70);"> 2012-06-14</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;">Topic: Primer design - Cloning: Sortase-Tag an VP2 + PCR for VP2 with Kozak-sortase_tag-myc_tag </P><P><B>Investigators:</B> Kathi, Laura, Tobias and Xenia </P><P><B>Aim:</B></P><P>Change primer of 2012-06-07, generate primers for the cmv region + cmv-suffix with SpeI restriction site, include XbaI restriction site in VP2-prefix include myc-tag</P><P><B>Materials:</B></P><UL><LI> Vector:P10_pSB1C3_001_CMV_DARPin_ML_VP2/3_587KO_6xHis
</LI></UL><UL><LI> Sortase-sequence: amino acid sequence: LTAPG translated to gene sequence: CTTACAGCCCCAGGA
</LI></UL><UL><LI> Kozak-sequence: gccgcc
</LI></UL><UL><LI> restriction sites: SpeI and XbaI </LI></UL><P><B>Method:</B> Geneious </P><P><B>Results:</B></P><UL><LI> f_Primer_preXba1 with overhang of: kozak+SortaseMotiv1+myc-tag+VP2 (forward primer)
</LI></UL><UL><LI> r_Primer_VP2_1 (reverse primer)
</LI></UL><UL><LI> f_Primer_XbaI+cmv (forward primer)
</LI></UL><UL><LI> r_Primer_CMV+suf (reverse primer)
</LI></UL><UL><LI> location: directory: VIRUS/complete</LI></UL><P><B>Further tasks:</B></P><UL><LI> control
</LI></UL><UL><LI> improvements
</LI></UL><UL><LI> order
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-19_2"><P style="background-color: rgb(240, 20, 70);"> 2012-06-19</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: Primer design - Cloning: Sortase-Tag linked on VP2 + PCR for VP2 with Kozak-sortase_tag-myc_tag</P><P><B>Investigators:</B> Kathi, Laura, Tobias, Xenia </P><P><B>Aim:</B> change primers of 2012-06-14</P><P><B>Materials:</B></P><UL><LI> vector:P10_pSB1C3_001_CMV_DARPin_ML_VP2/3_587KO_6xHis
</LI></UL><UL><LI> sortase-sequence: amino acid sequence: LTAPG translated to gene sequence: CTTACAGCCCCAGGA
</LI></UL><UL><LI> kozak-sequence: gccgcc
</LI></UL><UL><LI> restriction sites: SpeI and XbalI</LI></UL><P><B>Method:</B>Geneious</P><P><B>Results:</B></P><UL><LI> f_Primer_preXba1 with overhang: kozak+SortaseMotiv1+myc-tag+VP2 (forward primer)
</LI></UL><UL><LI> r_Primer_VP2_1-Temp. 80.3 °C (reverse primer)
</LI></UL><UL><LI> f_Primer_XbaI+Überhang_cmv (forward primer)
</LI></UL><UL><LI> r_Primer_CMV+suf (reversed)+ overhang (reverse primer)
</LI></UL><UL><LI> location: directory: VIRUS/complete </LI></UL><P><B>Further tasks:</B></P><UL><LI> control
</LI></UL><UL><LI> improvements
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-22_3"><P style="background-color: rgb(240, 20, 70);"> 2012-06-22</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: Primer design - Cloning: Sortase-Tag an VP2 + PCR for VP2 with Kozak-sortase_tag-myc_tag</P><P><B>Investigators:</B> Kathi, Laura, Tobias, Xenia </P><P><B>Aim:</B></P><UL><LI> change primer of 2012-06-19
</LI></UL><UL><LI> trim primer: r_Pst_Primer_VP2_1+overhang-to reduce temperature uo to 68 °C
</LI></UL><UL><LI> remove primers for cmv region</LI></UL><P><B>Materials:</B></P><UL><LI> Vector: p10_pSB1C3_001_CMV_DARPin_ML_VP2/3_587KO_6xHis
</LI></UL><UL><LI> Sortase-sequence: amino acid sequence: LTAPG translated to gene sequence: CTTACAGCCCCAGGA
</LI></UL><UL><LI> Kozak-sequence: gccgcc
</LI></UL><UL><LI> restriction sites: XbaI in forward primer for VP2 region</LI></UL><P><B>Method:</B>Geneious </P><P><B>Results:</B></P><UL><LI> prf_XbaI_kozak_SortaseMotivN_myc_VP2 (forward primer)
</LI></UL><UL><LI> prr_VP2_PstI_Temp68 (reverse primer)
</LI></UL><UL><LI> location: directory geneious VIRUS/complete</LI></UL><P><B>Further tasks:</B></P><UL><LI> control of the primer
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-28_2"><P style="background-color: rgb(240, 20, 70);"> 2012-06-28</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: TAE-buffer</P><P><B>Investigator:</B>Xenia</P><P><B>Aim:</B> TAE-buffer(50x)- 1l </P><P><B>Materials:</B></P><P>242 g tris base </P><P>57.1 mL glacial acetic acid </P><P>100 mL 0.5 M EDTA </P><P>add 1 L Millipore -water</P><P><B>Further tasks:</B></P><UL><LI>Agarose gel electrophoresis
</LI></UL><H3><SPAN class="mw-headline" id="2012-06-29"><P style="background-color: rgb(240, 20, 70);"> 2012-06-29</P></SPAN></H3><P style="background-color: rgb(238, 221, 130); font-weight: bold;"> Topic: Primer solution</P><P><B>Investigator:</B>Kathi </P><P><B>Aim:</B> primer solution in 100 µM </P><P><B>Materials:</B></P><UL><LI> prr_VP2_PstI_Temp68 ad 394 µL Aqua dest
</LI></UL><UL><LI> prf_XbaI_kozak_SortaseMotivN_myc_VP2 ad 178 µL Aqua dest</LI></UL><P><B>Results:</B></P><UL><LI> prf_XbaI_kozak_SortaseMotivN_myc_VP2 --&gt; c=100 µM
</LI></UL><UL><LI> prr_VP2_PstI_Temp68 --&gt; c=100 µM
</LI></UL><P><B>Further tasks:</B></P><UL><LI> PCR
</LI></UL></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:Potsdam_Bioware/Lab/Labjournal/June">http://2012.igem.org/Team:Potsdam_Bioware/Lab/Labjournal/June</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Potsdam_Bioware/Lab/Labjournal/June" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Potsdam_Bioware/Lab/Labjournal/June" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Potsdam_Bioware/Lab/Labjournal/June&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Potsdam_Bioware/Lab/Labjournal/June&amp;oldid=178740" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>